Clinical trial
Identification of a Responsive Subpopulation to Hydroxychloroquine in COVID-19 Patients Using Machine Learning: the IDENTIFY Trial
NCT04423991 is registered in ClinicalTrials.gov with Dascena as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Identification of a Responsive Subpopulation to Hydroxychloroquine in COVID-19 Patients Using Machine Learning: the IDENTIFY Trial
- Lead sponsor
- Dascena
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- March 10, 2020
- Completion date
- June 4, 2020
- Enrollment
- 290 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
coronavirus, covid-19, mortality